Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2003
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0806416B1 Huperzine a derivatives, their preparation and their use
05/07/2003EP0774961B1 Use of selegilin in the treatment of epilectic conditions
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0749417B1 Cyano compounds and preparations thereof
05/07/2003EP0722737B1 Use of HGF for the preparation of a medicament against CNS disorders
05/07/2003EP0665729B1 Biocompatible polymers containing diagnostic or therapeutic moieties
05/07/2003CN1416428A Compounds having antitumor activity: process for their prepn.and pharmaceutical compsns. contg. them
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1416420A 1,2,3,4-tetrahydroisoquinoline derivatives
05/07/2003CN1416352A Outer membrane vesicle (OMV) vaccine comprising N. Meningitidis serogroup B outer membrane
05/07/2003CN1416350A Novel method for down-regulation of amyloid
05/07/2003CN1416344A Novel wse of (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylamino methyl]-chromane and its physiologically acceptable salts
05/07/2003CN1416341A Stable emulsion compsns
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1416335A New self emulsifying drug delivery system
05/07/2003CN1415362A Ointment of Chinese traditional medicine for curing facial palsy
05/07/2003CN1415348A Sobering up buccal tablets and its preparation method
05/07/2003CN1415321A Sobering up sonvenient beverage
05/07/2003CN1415309A Nano selenium of Melatonin and its preparation method
05/07/2003CN1415308A Nano selenium of amino acid and its preparation method
05/07/2003CN1415303A Red sage root and Tienchi sustained release medication, its preparation method and medicinal application in vascular dementia
05/07/2003CN1415294A Long acting injection microsphere combination of naltrexone, its preparation method and application
05/07/2003CN1415285A Inhalant of Shumaputan dry-powder and its preparation method
05/07/2003CN1415253A Beverage for regulating spirit
05/07/2003CN1107669C 维生素d类似物 Vitamin d analogues
05/07/2003CN1107504C Use of leveobupivacaine in paediatric surgery
05/07/2003CN1107499C Nitric oxide donor compsns. and method for treating anal disorders
05/06/2003USRE38115 Treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction
05/06/2003US6559293 Topiramate sodium trihydrate
05/06/2003US6559190 Treating a mammal for neurointoxication, wherein said neurointoxication is caused by an excess of neurotransmitter in said mammal, said method comprising treating said mammal with a xenon-containing gas in an amount effective to reduce
05/06/2003US6559169 For therapy of depression, anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder attention deficit disorder,obsessive compulsive disorder, obesity, eating disorders, sexual dysfunction
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559166 A class of phenylsulphonyl derivatives wherein the sulphonyl moiety is also attached to an N-arylalkyl-substituted azetidine, pyrrolidine or piperidine ring are selective antagonists of the human 5-HT2A receptor and are therefore
05/06/2003US6559165 Prevention, treatment, or management of apnea, apnea disorders, bulimia nervosa, irritable bowel syndrome, urinary incontinence, bradycardia, bradyarrhythmia, syncope, other disorders, or symptoms thereof using (-) norcisapride, or salt
05/06/2003US6559163 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
05/06/2003US6559160 These compounds and compositions bind to the CXCR3 chemokine receptor and are useful for treating diseases and conditions responsive to the modulation of CXCR3 activity, such as multiple sclerosis, rheumatoid arthritis, psoriasis, cancer,
05/06/2003US6559159 Kappa opioid receptor ligands
05/06/2003US6559154 Composition of sodium channel blocking compound
05/06/2003US6559153 1-(4-(((4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino) methyl)-4-phenyl-piperidin-1-yl)-1-cyclopropyl-methanone; treating disease states ameliorated by blockade of alpha-1 adrenoceptors; sleep/psychological disorders
05/06/2003US6559148 Administering a therapeutically effective amount of a compound which is a P2Y purinoreceptor antagonist such as Basilen Blue
05/06/2003US6559146 Neuroprotective effects by inducing calbindin D28Kd, one of Ca2+-binding proteins
05/06/2003US6559141 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
05/06/2003US6558912 Screening for modulators of apoptosis; obtain cells containing apoptosis polypeptide, incubate with binding protein, expose to modulator, monitor concentration of bound protein in presence of modulator, compare to control
05/06/2003US6558701 Multilayer tablet for administering a fixed combination of tramadol and diclofenac
05/06/2003US6558696 Desoxypeganine
05/06/2003US6558692 Over-coated chewing gum formulations
05/02/2003EP1306437A2 Delta opioid receptor genes
05/02/2003EP1306429A1 Method of screening ptp zeta activity promoter or inhibitor
05/02/2003EP1306378A1 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
05/02/2003EP1306376A1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1306372A1 Heterocycle derivatives and drugs
05/02/2003EP1306093A1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
05/02/2003EP1306089A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics or calcium antagonists
05/02/2003EP1306088A1 Combination of a benzimidazole having angiotensin-II antagonistic activity with a diuretic
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1305635A2 Methods to identify compounds that modulate rage
05/02/2003EP1305406A2 Modulation of gamma-secretase activity
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305340A2 Sequences for integrin alpha-8
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305322A2 Derivatives of branched-chain lipophilic molecules and uses thereof
05/02/2003EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/02/2003EP1305318A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo 2,1-b] 1,3]benzotiazepines
05/02/2003EP1305316A2 Azabicyclic derivatives and their therapeutic use
05/02/2003EP1305315A2 Polymorphs of zaleplon and methods for the preparation thereof
05/02/2003EP1305313A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors
05/02/2003EP1305307A1 Indole derivatives useful for the treatment of cns disorders
05/02/2003EP1305306A2 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305303A1 NOVEL FORM OF (R)- i N /i - 5-METHYL-8-(4-METHYLPIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-2-NAPHTHYL]-4-MORPHOLINOBENZAMIDE
05/02/2003EP1305300A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
05/02/2003EP1305291A1 3-substituted isoquinolin-1-yl derivatives
05/02/2003EP1305285A1 N-substituted indoles useful in the treatment of diabetes
05/02/2003EP1305082A2 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
05/02/2003EP1305024A1 Method for treating fibrotic diseases or other indications ic
05/02/2003EP1305023A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis
05/02/2003EP1305021A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
05/02/2003EP1305015A1 Substituted styryl benzylsulfones for treating proliferative disorders
05/02/2003EP1304922A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
05/02/2003EP1223966B1 Use of gdnf for treating corneal defects
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1200064B1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip
05/02/2003EP1196167A4 Method of reducing neuronal injury or apoptosis
05/02/2003EP1185516B1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
05/02/2003EP1140061B1 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
05/02/2003EP1105388B1 N-substituted azabicycloheptane derivatives, production and use thereof
05/02/2003EP1100796B1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
05/02/2003EP1086103B1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1 specific ligands
05/02/2003EP1070058B1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
05/02/2003EP1056475B1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors
05/02/2003EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
05/02/2003EP0999840B1 Use of a draflazine analogue for treating pain
05/02/2003EP0988035B1 Caspases and apoptosis
05/02/2003EP0986396A4 Prion protein modulator factor (ppmf) and prion resistant animals
1 ... 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 ... 1833